← Eichor
Condition: Cirrhosis And Chronic Liver Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cirrhosis And Chronic Liver Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Microplastics, Cirrhosis and Portal Hypertension
Phase N/A · 2 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT072803902D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07122622Copper Supplementation in Cirrhosis
NA · 1 location(s) · University of Washington · NCT07471542Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06519162Biochemical Response and Clinical Outcomes in Patients With PBC
Phase N/A · 1 location(s) · RenJi Hospital · NCT07449793VACcination of LIver Transplantation Candidates
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT04446832CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05623150EUS Guided Portal-systemic Pressure Gradient Measurement
Phase 1/Phase 2 · 1 location(s) · Chinese University of Hong Kong · NCT04633356Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Bi
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT07715500Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Phase 4 · 1 location(s) · Mercy Medical Center · NCT04588077Effect of Some Drugs on Liver Fibrosis
Phase 3 · 1 location(s) · Sherief Abd-Elsalam · NCT03770936Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of D
Phase N/A · 2 location(s) · University of Oxford · NCT06658782SASL Swiss Cirrhosis Cohort
Phase N/A · 10 location(s) · University Hospital, Basel, Switzerland · NCT06092385Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis
Phase N/A · 3 location(s) · Singapore General Hospital · NCT07438288Natural History of Advanced Chronic Liver Diseases
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07042308hepatomiR cACLD Study
Phase N/A · 1 location(s) · Karl Landsteiner University of Health Sciences · NCT06432582Prediction of Significant Liver Fibrosis
Phase N/A · 1 location(s) · Huang Haijun · NCT06509230Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
Phase N/A · 1 location(s) · Association HGE CHU Bordeaux Sud · NCT02060565Comparison of Blood Products Required Using Two Different ROTEM Cut-offs Before Invasive Procedures in Cirrhosis and Acu
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06831565Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompens
NA · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06431919An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Phase N/A · 1 location(s) · University of Copenhagen · NCT05335603FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05095714Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospect
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06948565The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)
Phase N/A · 1 location(s) · University of Malaya · NCT07418008RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
Phase 1/Phase 2 · 14 location(s) · Resolution Therapeutics Limited · NCT06823713Assessing Signatures for Fibrosis Detection in Chronic Liver Disease: A Step Beyond Conventional Biomarkers
NA · 1 location(s) · Universitair Ziekenhuis Brussel · NCT07359742Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liv
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT07275554Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT017931683D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
Phase N/A · 1 location(s) · Shengjing Hospital · NCT05475015
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.